Hospitals / providers

The Transplant Is Not the Finish Line

Alzheimer’s Trials Still Measure Too Little, Too Late

Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress

Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach

Chemo Shortages Are Back. So Is Rationing.

The ICU Has a New Signal. It Is Not a Verdict.

West Nile Is Back. Blood Safety Cannot Lag.

Deep learning uncovers a new ECG biomarker for sudden cardiac death

Half of CKM patients go untreated and most fail control
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
